Newsfeeds Archive - Page 2 of 14

4 minute read

Why James Hardie Industries Shares Are Trading Lower By Around 14%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

May 21, 1:36 PM

Shares of James Hardie Industries plc (NYSE:JHX) fell sharply during Tuesday’s session after the company reported worse-than-expected quarterly…

AGRI

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

May 21, 12:31 PM

Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) stock increased by 84.3% to $2.34 during Tuesday’s regular session. The market value of…

AKAN

2 minute read

Crude Oil Moves Lower; Lowe’s Earnings Top Views

By Avi Kapoor

May 21, 12:00 PM

U.S. stocks traded mostly higher midway through trading, with the Dow Jones index gaining around 0.2% on Tuesday.…

AONC

2 minute read

Movers
News

What’s Going On With Biodexa Pharmaceuticals Stock?

By Dylan Berman

May 21, 10:45 AM

Biodexa Pharmaceuticals (NASDAQ:BDRX) stock is trading higher. The company on Tuesday announced progress towards the treatment of Familial Adenomatous Polyposis.

BDRX

2 minute read

US Stocks Mixed; Zoom Video Posts Upbeat Eatnings

By Avi Kapoor

May 21, 10:04 AM

U.S. stocks traded mixed this morning, with the Dow Jones index gaining around 0.1% on Tuesday. Following the…

AGRI

1 minute read

Biodexa Pharmaceuticals Presents Phase 2 Clinical Trial Results Of Its Newly-Licensed eRapa In Familial Adenomatous Polyposis Scheduled For Presentation At The 2024 Digestive Disease Week Annual Meeting; Reports Overall 83% Non-Progression Rate At 6 Mo…

By Benzinga Newsdesk

May 21, 8:38 AM

Biodexa Pharmaceuticals PLC("Biodexa" or the "Company")Positive Statistically Significant Phase 2 Clinical Trial Results of Biodexa's Newly-licensed eRapa™ in Familial Adenomatous Polyposis (FAP) Scheduled for

BDRX

2 minute read

Why Larimar Therapeutics Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket

By Avi Kapoor

May 21, 8:12 AM

Shares of Larimar Therapeutics, Inc.. (NASDAQ:LRMR) rose sharply in today’s pre-market trading after the company announced that the…

AGRI

1 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Pre-Market Session

By Benzinga Insights

May 21, 8:06 AM

Gainers Biodexa Pharmaceuticals (NASDAQ:BDRX) shares increased by 67.7% to $2.13 during Tuesday’s pre-market session. The market value of…

AKAN

2 minute read

Biodexa’s Licensor Emtora To Announce Phase 2 Clinical Trial Results Of eRapa In Familial Adenomatous Polyposis To Be Presented At Prestigious 2024 Digestive Disease Week Annual Meeting

By Benzinga Newsdesk

April 30, 11:53 AM

Biodexa's Licensor Emtora to Announce Phase 2 Clinical Trial Results of eRapa™ in Familial Adenomatous Polyposis to be Presented at Prestigious 2024 Digestive Disease Week Annual MeetingBiodexa Pharmaceuticals

BDRX